Dale G. Ando
2012
In 2012, Dale G. Ando earned a total compensation of $1M as Vice President, Therapeutic Development and Chief Medical Officer at Sangamo Biosciences, a 59% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $128,250 |
|---|---|
| Option Awards | $265,020 |
| Salary | $427,500 |
| Stock Awards | $189,350 |
| Total | $1,010,120 |
Ando received $427.5K in salary, accounting for 42% of the total pay in 2012.
Ando also received $128.3K in non-equity incentive plan, $265K in option awards and $189.4K in stock awards.
Rankings
In 2012, Dale G. Ando's compensation ranked 6,086th out of 11,487 executives tracked by ExecPay. In other words, Ando earned more than 47.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,086 out of 11,487 | 47th |
Division Manufacturing | 2,164 out of 4,253 | 49th |
Major group Chemicals And Allied Products | 547 out of 1,203 | 55th |
Industry group Drugs | 372 out of 925 | 60th |
Industry Biological Products, Except Diagnostic Substances | 61 out of 165 | 63rd |
Source: SEC filing on March 11, 2014.
Ando's colleagues
We found four more compensation records of executives who worked with Dale G. Ando at Sangamo Biosciences in 2012.